1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: generic
Raku Co..Ltd

Raku Co..Ltd

TTPEX:4154
12.60
TWD
+0.70
(+5.88%)
-0.92EPS
481.79MMarket Cap
Raku Co..Ltd
TPEX:4154
(Taipei Exchange)

Recent

price

12.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
7.42
30.46
26.83
23.72
31.17
35.78
40.42
33.47
33.8
42.43
32.76
18.36
17.82
11.33
1.57
0.8
0.82
Revenue per Share
1.12
4.9
4.69
0.82
1.58
-1.63
0.99
-2.85
-2.99
-3.22
-1.68
-3.15
-1.42
-4.41
-4.75
-1.82
-0.89
Basic EPS, GAAP
-0.58
6.2
3.41
1.3
0.43
-2.7
-2.22
-2.98
-0.15
1.08
-7.28
-8.41
-4.27
1.95
-1.88
-2.07
-0.87
Free Cash Flow per Basic Share
- -
- -
2.29
3.19
0.77
1.45
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
14.82
22.57
24.61
21.96
21.1
16.47
16.5
13.66
15.77
12.44
10.69
13.44
12.86
8.65
7.18
6.36
6.19
Book Value per Share
14.82
22.57
24.61
21.96
21.1
15.74
15.09
11.91
14.84
12.39
10.48
13.29
12.71
8.56
7.02
6.35
6.17
Tangible Book Value per Share
10
12
15
15
14
14
13
13
15
17
17
22
25
25
26
33
36
Basic Weighted Avg Shares
75
368
404
357
450
483
545
451
496
713
550
401
440
279
41
27
30
Sales/Revenue/Turnover
16.08
18.7
18.76
2.8
4.73
-2.59
-5.03
-9.99
-10.35
-6.42
-6.35
-25.14
-8.21
-37.54
-231.62
-237.57
-109.87
Operating Margin (%)
- -
3
4
5
7
7
9
13
17
37
20
28
37
46
37
18
15
Depreciation Expense
11
59
71
12
23
-22
13
-38
-44
-54
-28
-69
-35
-109
-125
-61
-32
Net Income, GAAP
8.76
0.12
2.93
14.29
11.19
- -
14.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
15.05
16.09
17.48
3.47
5.07
-4.56
2.44
-8.5
-8.84
-7.6
-5.11
-17.19
-7.95
-38.96
-301.66
-226.31
-107.76
Profit Margin (%)
108
295
325
283
218
142
162
122
225
216
112
101
5
14
53
71
38
Working Capital
8
41
37
34
12
7
2
2
1
27
23
16
6
3
2
- -
- -
LT Debt
126
340
370
330
294
222
222
184
284
250
258
398
368
243
234
236
251
Total Equity
11.53
22.99
17.6
2.21
5.57
- -
-9.3
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
13.83
21.17
17.72
3.85
7.21
- -
5.91
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
17.99
25.42
19.88
3.53
7.29
-8.54
5.98
-18.87
-19.52
-22.85
-14.49
-26.96
-10.78
-41.03
-57.43
-27.3
-13.76
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7
7
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
35
38
38
Market Capitalization
555
551
482

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
117
158
101
Cash, Cash Equivalents & STI
73
60
67
Accounts Receivable, Net
- -
1
1
Inventories
- -
- -
- -
Total Current Liabilities
46
61
62
Payables & Accruals
- -
- -
- -
ST Debt
7
7
1
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.83%
1.98%
0.63%
Free Cash Flow
-206.79%
-60.22%
39.68%
Net Income, GAAP
-28.91%
54.03%
-51.46%
Sales/Revenue/Turnover
-14.8%
-34.89%
-35.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7
15
10
10
41
2025
6
3
7
10
27
2026
5
7
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-1.28
-1.05
-0.91
-1.45
-4.75
2025
-0.74
-0.64
-0.3
-0.2
-1.82
2026
-0.25
-0.15
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (TASE:TEVA)
Jagsonpal Pharmaceuticals Ltd. (NSE:JAGSNPHARM)
Zim Laboratories Ltd. (NSE:ZIMLAB)
Paradigm Biopharmaceuticals Ltd. (ASX:PAR)
Neuren Pharmaceuticals Limited (ASX:NEU)
Business
Raku Co., Ltd (4154.TWO) engages in the manufacturing, trading and sale of luxury boutique accessories, including metal buttons and fittings for leather products; develops and sells functional drinks and healthcare and beauty products; operates food service, restaurant and entertainment businesses, including art activities and ticket brokerage; and pursues other related operations. The company conducts its activities in Malaysia, Singapore, China, Taiwan, Thailand, Europe and internationally. Incorporated in 2000 and headquartered in Camana Bay, the Cayman Islands, Raku formerly operated as Kino Co., Ltd., changing its name in October 2021 amid a strategic reform that integrated expertise from the KINO team in international strategy and financial planning; it established its first concept factory in Taiwan in 2020, launched a customized factory in Bangkok, Thailand in 2021 with volume production commencing in 2022, and announced a private placement of up to 15 million common shares for funding in early 2025 along with investments in entities such as Raku Holdings Co., Ltd. and True Co., Ltd.